Navigation Links
Hospitalists at New England Baptist Hospital Choose MedAptus
Date:2/16/2011

BOSTON, Feb. 16, 2011 /PRNewswire/ -- MedAptus®, the market leader for charge capture technologies, today announced that New England Baptist Hospital (NEBH) has selected the company's Professional Intelligent Charge Capture technology for its inpatient medicine providers. The NEBH hospitalist team, comprised of both physicians and nurse practitioners, will access MedAptus' Inpatient Edition via the web as well as iPhone® and BlackBerry® devices.  

NEBH, located in Boston, offers nationally recognized expertise in orthopedic surgery, built on more than a century of experience. The hospital has been named a top orthopedic hospital by U.S. News & World Report and is additionally a teaching affiliate of Tufts University School of Medicine.

MedAptus' Inpatient Edition was designed specifically to meet the needs of hospital-based providers. A robust yet easy-to-use rounding list feature, integrated messaging and embedded pay-for-performance logic ensure optimal reimbursement and productivity for busy hospitalists that provide care for many patients over long shifts. MedAptus' companion Reconciliation, Coding & Administration dashboard provides Inpatient Edition customers with admission-based reconciliation views, rounding list management capabilities and exception-based charge management.

NEBH executives reached out to MedAptus to help the hospital improve its approach to professional charge capture and management. Prior to engaging MedAptus, the hospitalist providers utilized paper charge slips to document patient encounters. Completed forms were then sent to the group's billing vendor. By replacing paper with technology, the entire process will be executed electronically, expediting time-to-payment for the group.

"We selected MedAptus in order to accomplish two key objectives - decreasing charge lag and increasing cash flow. Beyond the technology's ability to help us achieve those ends, we also recognized other system benefits. As one example, real-time census updates from the MEDITECH hospital system let providers know exactly where their patients are located, a gain for provider efficiency," said Lauren B. Finnegan, director of physician relations and offices at New England Baptist Hospital.

"The addition of New England Baptist Hospital to the MedAptus customer base means further expansion of our sizable provider presence in the Northeast. We are of course excited to deploy our software at an organization known for groundbreaking orthopedic advancements and expect the clinician-users there to embrace our technology as a tool that drives personal, team and operational efficiencies," said David Delaney, MD, MedAptus' chief medical officer.

About MedAptus CorporationMedAptus is the Gold Standard in the healthcare revenue cycle for achieving effective charge management, compliance and workflow efficiency. With offerings that range from powerful and easy-to-use Intelligent Charge Capture technologies to high-impact revenue cycle consulting services, it is no wonder that many of the nation's most prestigious healthcare organizations rely on MedAptus for financial optimization. Our solutions, which include full-scale Professional and Facility applications, increase revenue, enhance EMR investments, re-engineer manual processes and yield substantially improved productivity. For more information, visit http://www.medaptus.com or call 617.896.4000.MedAptus Contact: Jennifer Crowleyp. 617.896.4030jcrowley@medaptus.com  This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>

SOURCE MedAptus Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New England Biolabs Releases JoVE Video Protocol Highlighting Assay to Quantitate 5-hmC in Epigenome
2. New England Patriots Offensive Line Wins Second Annual Madden Most Valuable Protectors Award Presented by Prilosec OTC®
3. Pescatello Elected to Head New England Biotech Association in 2011-12
4. Positive Phase II Results with Iniparib (BSI-201) in Women with Metastatic Triple Negative Breast Cancer Published in The New England Journal of Medicine
5. Study Published in New England Journal of Medicine Shows Nplate® Significantly Reduces Treatment Failure and Splenectomy Rate in Patients With Chronic ITP
6. Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
7. New England Biolabs Launches a Suite of Innovative Tools to Advance Epigenetics Research, Including PCR-Based Assay to Identify and Quantitate 5-hmC in Epigenome
8. New England Biolabs Receives Award to Develop Novel Enzymatic Reagents for Epigenetic Studies
9. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
10. New England Biolabs Launches NEBNext™ Quick DNA Sample Prep Reagent Sets for Use With Roche/454 Next Generation Sequencing Platforms
11. The New England Journal of Medicine Publishes Results of Landmark CREST Study, Showing Similar Positive Outcomes for Abbotts Carotid Stent System and Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Jan. 18, 2017  Dermata Therapeutics, LLC, a ... treat a variety of dermatological diseases, announces dosing ... in a Phase 2 acne rosacea study. DMT210 ... the proinflammatory cytokines in the skin responsible for ... This clinical trial, DMT210-003, is ...
(Date:1/18/2017)... , January 18, 2017 The report " Automated Breast ... Breast Volume Scanner), By End User (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, ... Argentina , Germany , UK, ... Russia , China , Japan ... Thailand , Saudi Arabia , UAE, ...
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC today ... granted a Rare Pediatric Disease (RPD) designation for the ... Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin disorder. ... treatment is limited to supportive care. "The ... Drug Designation previously granted by the FDA in this ...
Breaking Medicine Technology:
(Date:1/18/2017)... USA; and SHANGHAI, China – , ... ... -- Global public health organization NSF International has certified the ... to NSF/ANSI 53: Drinking Water Treatment Units – Health Effects, ... certification verifies that MicroCeramics’ NanoNose Pitcher Filter System filters the ...
(Date:1/18/2017)... ... January 18, 2017 , ... A Palm Beach doctor plans ... Train, an international charity that provides free surgery to poor children suffering from cleft ... the past I have run to support the efforts of the American Heart Association ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... asset protection and financial planning services to families and business owners in the ... aimed at supporting children with developmental disabilities. , The Lakemary Center is a ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent ... for drugs, biologics and consumer health products, today announced that Mr. Michael Merges, ... upcoming WCBP Conference, to be held at the Mayflower Hotel, Washington DC, on ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... of the revolutionary Active Brake Technology (ABT), an innovative braking system that allows ... Active Brake Technology addresses one of the biggest concerns of beginner and intermediate ...
Breaking Medicine News(10 mins):